Unilever’s strategy in spotlight after dropping $68 billion GSK battle
Unilever’s (ULVR.L) strategy was under the investor microscope on Thursday after the consumer goods giant effectively abandoned its $68 billion pursuit of GlaxoSmithKline’s (GSK.L) consumer healthcare business. Shares in Unilever,…